Log in to save to my catalogue

Grapefruit-medication interactions: forbidden fruit or avoidable consequences?

Grapefruit-medication interactions: forbidden fruit or avoidable consequences?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3589309

Grapefruit-medication interactions: forbidden fruit or avoidable consequences?

About this item

Full title

Grapefruit-medication interactions: forbidden fruit or avoidable consequences?

Publisher

Canada: Joule Inc

Journal title

Canadian Medical Association journal (CMAJ), 2013-03, Vol.185 (4), p.309-316

Language

English

Formats

Publication information

Publisher

Canada: Joule Inc

More information

Scope and Contents

Contents

Although some pharmacokinetic studies have tested a higher than usual amount of grapefruit juice to determine the maximum effect, this should not be interpreted to mean that a relevant pharmacokinetic interaction will only occur with high levels of consumption. Indeed, a single usual amount (i.e., 200-250 mL juice or a whole grapefruit) has suffici...

Alternative Titles

Full title

Grapefruit-medication interactions: forbidden fruit or avoidable consequences?

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3589309

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3589309

Other Identifiers

ISSN

0820-3946

E-ISSN

1488-2329

DOI

10.1503/cmaj.120951

How to access this item